🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
There are two parts to this study: the goal of the first part of the study ...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2015-08-31
Trial ID
NCT02352831
Treatments Being Tested
This is an open-label, multicenter, multiple-dose, Phase I-II study of CHR-...
Status
Terminated
Location
Tower Cancer Research Foundation
Start Date
2007-12
Trial ID
NCT00522938
Treatments Being Tested
Study WCMC IST-CTI-MDS evaluates the safety and tolerability of tosedostat ...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2015-03-20
Trial ID
NCT02452346
Treatments Being Tested
This study examines a new oral chemotherapy drug called tosedostat, in comb...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2012-05
Trial ID
NCT01567059
Treatments Being Tested
The treatment of cancer often involves the use of more than one drug at the...
Status
Completed
Location
UMC St Radboud
Start Date
2006-08
Trial ID
NCT00737555
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of cytarabine ...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2012-11-20
Trial ID
NCT01636609
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of tosedos...
Status
Completed
Location
UCLA School of Medicine
Start Date
2009-10
Trial ID
NCT00780598
Treatments Being Tested
The purpose of this study is to evaluate the long-term efficacy and safety ...
Status
Unknown
Location
UCLA Division of Hematology/Oncology
Start Date
2010-06
Trial ID
NCT01180426
Treatments Being Tested
The primary objective of this study was to determine the safety, tolerabili...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00692354
Treatments Being Tested
The objectives of this study are to evaluate the safety and tolerability; a...
Status
Completed
Location
Covance Clinical Research Unit Inc.
Start Date
2012-06
Trial ID
NCT01638442